[go: up one dir, main page]

GB201819943D0 - Immunotherapeutic treatment of cancer - Google Patents

Immunotherapeutic treatment of cancer

Info

Publication number
GB201819943D0
GB201819943D0 GBGB1819943.0A GB201819943A GB201819943D0 GB 201819943 D0 GB201819943 D0 GB 201819943D0 GB 201819943 A GB201819943 A GB 201819943A GB 201819943 D0 GB201819943 D0 GB 201819943D0
Authority
GB
United Kingdom
Prior art keywords
cancer
immunotherapeutic treatment
immunotherapeutic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1819943.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immodulon Therapeutics Ltd
Original Assignee
Immodulon Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immodulon Therapeutics Ltd filed Critical Immodulon Therapeutics Ltd
Publication of GB201819943D0 publication Critical patent/GB201819943D0/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
GBGB1819943.0A 2017-12-08 2018-12-06 Immunotherapeutic treatment of cancer Ceased GB201819943D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762596220P 2017-12-08 2017-12-08

Publications (1)

Publication Number Publication Date
GB201819943D0 true GB201819943D0 (en) 2019-01-23

Family

ID=65030169

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1819943.0A Ceased GB201819943D0 (en) 2017-12-08 2018-12-06 Immunotherapeutic treatment of cancer

Country Status (1)

Country Link
GB (1) GB201819943D0 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008047359A2 (en) 2006-10-17 2008-04-24 Nanopass Technologies Ltd. Injection device and method
WO2017151727A1 (en) 2016-03-01 2017-09-08 North Carolina State University Enhanced cancer immunotherapy by microneedle patch-assisted delivery
WO2017189259A2 (en) 2016-04-29 2017-11-02 Kimberly-Clark Worldwide, Inc. Microneedle array assembly and fluid delivery apparatus having such an assembly
WO2017189258A2 (en) 2016-04-29 2017-11-02 Kimberly-Clark Worldwide, Inc. Microneedle array assembly, drug delivery device and method for administering liquid across a broad area at low pressure

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008047359A2 (en) 2006-10-17 2008-04-24 Nanopass Technologies Ltd. Injection device and method
WO2017151727A1 (en) 2016-03-01 2017-09-08 North Carolina State University Enhanced cancer immunotherapy by microneedle patch-assisted delivery
WO2017189259A2 (en) 2016-04-29 2017-11-02 Kimberly-Clark Worldwide, Inc. Microneedle array assembly and fluid delivery apparatus having such an assembly
WO2017189258A2 (en) 2016-04-29 2017-11-02 Kimberly-Clark Worldwide, Inc. Microneedle array assembly, drug delivery device and method for administering liquid across a broad area at low pressure

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Remington's Pharmaceutical Sciences", 1990, PRINTING COMPANY, pages: 1289 - 1329
WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546

Similar Documents

Publication Publication Date Title
IL275663A (en) Methods of treating cancer
IL289297B1 (en) Adjuvant treatment of her2-positive breast cancer
LT3622953T (en) Combination treatment of cancer
PT3576740T (en) Cancer treatment
IL266324A (en) Treatment of her2-positive breast cancer
IL268463A (en) Cancer treatment
SG11202011117VA (en) Treatment of cancer
IL270329B2 (en) Immunotherapeutic tumor treatment method
GB201706451D0 (en) Cancer treatment
ZA201908539B (en) Method of treatment of cancer
IL263835A (en) Exosome-guided treatment of cancer
IL274626A (en) Cancer treatment
GB201919428D0 (en) Immunotherapeutic treatment of cancer
IL267613A (en) Treatment of pancreatic cancer
SG11202005163PA (en) Methods of treating cancer
IL274748A (en) Improved treatment of cancer
GB201707864D0 (en) Platinum-reistant cancer treatment
IL269123A (en) Methods of treating cancer
GB201820098D0 (en) Methods of cancer treatment
GB201820975D0 (en) Methods of cancer treatment
GB201819943D0 (en) Immunotherapeutic treatment of cancer
GB201704287D0 (en) Treatment of cancer
GB201703857D0 (en) Treatment of cancer
GB201702565D0 (en) Treatment of cancer
GB201702139D0 (en) Methods of cancer treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)